These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 24130358)

  • 1. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD).
    Goldfine AB; Buck JS; Desouza C; Fonseca V; Chen YD; Shoelson SE; Jablonski KA; Creager MA;
    Diabetes Care; 2013 Dec; 36(12):4132-9. PubMed ID: 24130358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to comment on Goldfine et al. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD). Diabetes care 2013;36:4132-4139.
    Goldfine AB; Jablonski KA; Shoelson SE; Creager MA;
    Diabetes Care; 2014 May; 37(5):e112. PubMed ID: 24757239
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on Goldfine et al. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD). Diabetes care 2013;36:4132-4139.
    Pierce GL; Siefers K; Wegman-Points L
    Diabetes Care; 2014 May; 37(5):e110-1. PubMed ID: 24757238
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes.
    Lee SJ; Lee DW; Kim KS; Lee IK
    Diabetes Res Clin Pract; 2001 Dec; 54 Suppl 2():S81-92. PubMed ID: 11733113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with omega-3 polyunsaturated fatty acids does not improve endothelial function in patients with type 2 diabetes and very high cardiovascular risk: A randomized, double-blind, placebo-controlled study (Omega-FMD).
    Siniarski A; Haberka M; Mostowik M; Gołębiowska-Wiatrak R; Poręba M; Malinowski KP; Gąsior Z; Konduracka E; Nessler J; Gajos G
    Atherosclerosis; 2018 Apr; 271():148-155. PubMed ID: 29518747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial.
    Goldfine AB; Fonseca V; Jablonski KA; Chen YD; Tipton L; Staten MA; Shoelson SE;
    Ann Intern Med; 2013 Jul; 159(1):1-12. PubMed ID: 23817699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial.
    Goldfine AB; Fonseca V; Jablonski KA; Pyle L; Staten MA; Shoelson SE;
    Ann Intern Med; 2010 Mar; 152(6):346-57. PubMed ID: 20231565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients.
    Hamilton SJ; Chew GT; Davis TM; Watts GF
    Clin Sci (Lond); 2010 Feb; 118(10):607-15. PubMed ID: 20047560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation.
    Hausberg M; Kosch M; Stam F; Heidenreich S; Kisters K; Rahn KH; Barenbrock M
    Kidney Int; 2001 Apr; 59(4):1473-9. PubMed ID: 11260410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudy.
    Harmer JA; Keech AC; Veillard AS; Skilton MR; Marwick TH; Watts GF; Meredith IT; Celermajer DS;
    Atherosclerosis; 2015 Sep; 242(1):295-302. PubMed ID: 26233916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Targeting Inflammation With Salsalate: The TINSAL-CVD Randomized Clinical Trial on Progression of Coronary Plaque in Overweight and Obese Patients Using Statins.
    Hauser TH; Salastekar N; Schaefer EJ; Desai T; Goldfine HL; Fowler KM; Weber GM; Welty F; Clouse M; Shoelson SE; Goldfine AB;
    JAMA Cardiol; 2016 Jul; 1(4):413-23. PubMed ID: 27438317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study.
    Warnholtz A; Wild P; Ostad MA; Elsner V; Stieber F; Schinzel R; Walter U; Peetz D; Lackner K; Blankenberg S; Munzel T
    Atherosclerosis; 2009 May; 204(1):216-21. PubMed ID: 18822413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factor-{kappa}B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans.
    Pierce GL; Lesniewski LA; Lawson BR; Beske SD; Seals DR
    Circulation; 2009 Mar; 119(9):1284-92. PubMed ID: 19237660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes.
    Faghihimani E; Aminorroaya A; Rezvanian H; Adibi P; Ismail-Beigi F; Amini M
    Acta Diabetol; 2013 Aug; 50(4):537-43. PubMed ID: 21938543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salsalate improves glycaemia in overweight persons with diabetes risk factors of stable statin-treated cardiovascular disease: A 30-month randomized placebo-controlled trial.
    Salastekar N; Desai T; Hauser T; Schaefer EJ; Fowler K; Joseph S; Shoelson SE; Goldfine AB;
    Diabetes Obes Metab; 2017 Oct; 19(10):1458-1462. PubMed ID: 28295931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment.
    Chan DC; Wong AT; Yamashita S; Watts GF
    Atherosclerosis; 2012 Apr; 221(2):484-9. PubMed ID: 22341868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study.
    Pitocco D; Zaccardi F; Tarzia P; Milo M; Scavone G; Rizzo P; Pagliaccia F; Nerla R; Di Franco A; Manto A; Rocca B; Lanza GA; Crea F; Ghirlanda G
    Diabetes Obes Metab; 2013 May; 15(5):427-31. PubMed ID: 23167274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes--a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial.
    Balletshofer BM; Goebbel S; Rittig K; Enderle M; Schmölzer I; Wascher TC; Ferenc Pap A; Westermeier T; Petzinna D; Matthaei S; Häring HU
    Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):324-30. PubMed ID: 15977099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial function in patients with newly diagnosed type 2 diabetes receiving early intensive insulin therapy.
    Tian J; Wang J; Li Y; Villarreal D; Carhart R; Dong Y; Wen Y; Liu K
    Am J Hypertens; 2012 Dec; 25(12):1242-8. PubMed ID: 22895449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus.
    Kelly AS; Thelen AM; Kaiser DR; Gonzalez-Campoy JM; Bank AJ
    Vasc Med; 2007 Nov; 12(4):311-8. PubMed ID: 18048467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.